Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus

Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus

Background: The success of treatment of chronic hepatitis C (CHC) with pegylated interferon-α (PEG-IFN-α) and ribavirin (RBV) is affected by several host, viral, and treatment factors. This study was designed to describe the association of interleukin (IL) 28B genotypes for rs12979860 with sustained...

Full description

Bibliographic Details
Main Authors: Hamid Kalantari, Tahmine Tavakoli, Bahram Bagherpour, Shahram Honarmand
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Chronic hepatitis C
interleukin-28B
pegylated interferon-α
ribavirin
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2014;volume=19;issue=11;spage=1062;epage=1067;aulast=Kalantari

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2014;volume=19;issue=11;spage=1062;epage=1067;aulast=Kalantari

Similar Items